[Form 3] Sol-Gel Technologies Ltd. Initial Statement of Beneficial Ownership
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Sol-Gel Technologies Ltd. Chairman and CEO Moshe Arkin filed an initial ownership report showing his stake in the company. He reports indirect ownership of warrants giving the right to buy 200,000 ordinary shares at an exercise price of $58.50 per share, expiring on January 27, 2028, through M. Arkin Dermatology Ltd. He also reports 143,257 ordinary shares held directly and 1,606,856 ordinary shares held indirectly through M. Arkin Dermatology Ltd. A footnote states he disclaims beneficial ownership of these securities except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Arkin Moshe
Role
Chairman of Board and CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Warrants (right to buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Warrants (right to buy) — 200,000 shares (Indirect, By M. Arkin Dermatology Ltd.);
Ordinary Shares — 143,257 shares (Direct);
Ordinary Shares — 1,606,856 shares (Indirect, By M. Arkin Dermatology Ltd.)
Footnotes (1)
- Ordinary shares, NIS 1.00 par value per share. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
